Fadi Hakki

Fadi Hakki is a seasoned professional in the biopharmaceutical industry with 25 years of experience in the drug development lifecycle of biologics. Over a decade was spent as the global Regulatory Affairs-CMC lead for the Fasenra® (benralizumab) program at MedImmune, followed by leading the global Regulatory Affairs-CMC for Uplizna® (inebilizumab-cdon) at Viela Bio. Currently, Fadi serves as a Regulatory Affairs-CMC SME at Abcentra, managing marketing applications, lifecycle management studies, and the clinical portfolio. Fadi holds a Bachelor's Degree in Microbiology and Immunology from the University of Maryland College Park and a Master's Degree in Biotechnology from The Johns Hopkins University.